Skip to main content
Log in

Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Controversial data were reported on GH response to different provocative stimuli in obese patients with polycystic ovary syndrome (PCOS). The objective of our study was to assess the effect of short-term fasting on GH response to combined stimulus with GHRH+GH-releasing peptide-6 (GHRP-6) in obese patients with PCOS and possible relation with leptin and insulin changes during fasting. Twelve obese PCOS women and nine obese control women participated in 3-day fasting. GH response, IGF-I, insulin and leptin were measured after GHRH+ GHRP-6, before and after short-term fasting. Obese PCOS patients had significantly greater GH peak after GHRH+GHRP-6 before fasting. Enhanced response to GH stimulation was found after fasting without substantial differences between obese PCOS and obese controls. Insulin and leptin significantly decreased, while insulin sensitivity significantly improved in both groups during fasting. In conclusion, obese PCOS patients have peculiar type of GH response to GHRH+GHRP-6 before fasting, possibly due to enhanced sensitivity of somatotrophs. Observed changes in insulin and leptin may participate in modulation of enhanced GH response after short-term fasting to GHRH+GHRP-6 in PCOS and obese controls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Morales A.J. Role of growth hormone in polycystic ovarian syndrome. Semin. Reprod. Endocrinol. 1977, 15: 177–182.

    Article  Google Scholar 

  2. Franks S. Growth hormone and ovarian function. Bailliere’s Clin. Endocrinol. Metab. 1998, 12: 331–340.

    CAS  Google Scholar 

  3. Kaltsas T., Pontikides N., Krassas G.E., Seferiadis K., Lolis D., Messinis I.E. Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome. Hum. Reprod. 1999, 14: 2704–2708.

    Article  CAS  PubMed  Google Scholar 

  4. Maccario M., Tassone F., Grottoli S., Rossetto R., Gauna C., Ghigo E. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann. Endocrinol. 2002, 63: 140–144.

    CAS  Google Scholar 

  5. Villa P., Soranna L., Mancini A., et al. Effect of feeding on growth hormone response to growth hormone-releasing hormone in polycystic ovarian syndrome: relation with body weight and hyperinsulinism. Hum. Reprod. 2001, 16: 430–434.

    Article  CAS  PubMed  Google Scholar 

  6. Micić D., Kendereski A., Popović V., et al. Growth hormone response to GHRH, GHRP-6 and GHRH+GHRP-6 in patients with polycystic ovary syndrome. Clin. Endocrinol. 1996, 45: 385–390.

    Article  Google Scholar 

  7. Penalva A., Gaztambide S., Vazquez J.A., Dieguez C., Casanueva F.F. Role of cholinergic muscarinic pathways on the free fatty acid inhibition of GH responses to GHRH in normal men. Clin. Endocrinol. 1990, 33: 171–176.

    Article  CAS  Google Scholar 

  8. Melmed S. Insulin suppresses growth hormone secretion by rat pituitary cells. J. Clin. Invest. 1984, 73: 1425–1433.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Low L.C.K. Growth hormone-releasing hormone: clinical studies and therapeutic aspects. Neuroendocrinology 1991, 53: 37–40.

    Article  PubMed  Google Scholar 

  10. Ho K.Y., Veldhuis J.D., Johnson M.L., et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J. Clin. Invest. 1988, 81: 968–975.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Rasmussen M.H., Juul A., Kjems L.L., Skakkebaek N.E., Hilsted J. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J. Clin. Endocrinol. Metab. 1995, 80: 796–801.

    CAS  PubMed  Google Scholar 

  12. Casanueva F.F., Dieguez C. Growth hormone secretato-gogues, physiological role and clinical utility. Trends Endocrinol. Metab. 1999, 10: 30–38.

    Article  CAS  PubMed  Google Scholar 

  13. Adams J., Polson D.W., Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. 1986, 293: 355–359.

    Article  CAS  Google Scholar 

  14. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment insulin resistance and beta-cell function from fasting glucose and insulin concentration in man. Diabetologia 1985, 28: 412–419.

    Article  CAS  PubMed  Google Scholar 

  15. Piaditis G.P., Kounadi T.G., Rangou D.B., et al. Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome. Clin Endocrinol. 1995, 42: 635–640.

    Article  CAS  Google Scholar 

  16. Lanzone A., Villa P., Fulhesu A.M., Pavone V., Caruso A., Mancuso S. The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relatioship with obesity and hyperinsulinaemia. Hum. Reprod. 1995, 10: 1653–1657.

    CAS  PubMed  Google Scholar 

  17. Prelević G.M., Wurzburger M.I., Balint-Perić L., Ginsburg J. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-1 concentrations in women with polycystic ovaries. Horm. Metab. Res. 1992, 37: 125–131.

    Article  Google Scholar 

  18. Garcia-Rudaz M.C., Ropelato M.G., Escobar M.E., Veldhuis J.D., Barontini M. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome. Eur. J. Endocrinol. 2002, 147: 207–216.

    Article  CAS  PubMed  Google Scholar 

  19. Scachi M., Pincelli A.I., Cavagnini F. Growth hormone in obesity. Int. J. Obes. Relat. Metab. Disord. 1999; 23: 260–271.

    Article  Google Scholar 

  20. Cordido F., Penalva A., Dieguez C., Casanueva F.F. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marker somatotroph secretory capability in obesity. J. Clin. Endocrinol. Metab. 1993, 76: 819–823.

    CAS  PubMed  Google Scholar 

  21. Popović V., Pekić S., Simić M., et al. Physical activity or food intake prior to testing did not affect the reproducibility of GH secretion elicited by GH releasing hormone plus GH-releasing hexapeptide in normal adult subjects. Clin. Endocrinol. 2002, 56: 89–94.

    Article  Google Scholar 

  22. Carlson H.E., Drenick E.J., Chopra I.J., Hershman J.M. Alterations in basal and TRH-stimulated serum levels of thyrotropin, prolactin, and thyroid hormones in starved obese men. J. Clin. Endocrinol. Metab. 1977, 45: 707–713.

    Article  CAS  PubMed  Google Scholar 

  23. Procopio M., Maccario M., Grottoli S., et al. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Clin. Endocrinol. 1995, 43: 665–669.

    Article  CAS  Google Scholar 

  24. Megia A., Herranz L., Luna R., Gomez-Candela C., Pallardo F., Gonzalez-Gancedo P. Protein intake during aggressive calorie restriction in obesity determines growth hormone response to growth hormone-releasing hormone after weight loss. Clin. Endocrinol. 1993, 39: 217–220.

    Article  CAS  Google Scholar 

  25. Muller A.F., Janssen J.A., Lamberts S.W., et al. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion. Clin. Endocrinol. 2001, 55: 461–467.

    Article  CAS  Google Scholar 

  26. Penalva A., Pombo M., Carballow A., Barreiro J, Casanueva F.F., Dieguez C. Influence of sex, age, and adrenergic pathways on the growth hormone response to GHRP-6. Clin. Endocrinol. 1993, 38: 87–91.

    Article  CAS  Google Scholar 

  27. Leal A., Lage M., Popović V., et al. A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test. Clin. Endocrinol. 2002, 57: 377–384.

    Article  CAS  Google Scholar 

  28. Carro E., Senaris R.M., Seoane L.M., et al. Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion. Neuroendocrinology 1999, 69: 3–10.

    Article  CAS  PubMed  Google Scholar 

  29. Cocchi D., De Gennaro Colonna V., Bagnasco M., Bonacci D., Muller E.E. Leptin regulates GH secretion in the rat by acting on GHRH and somatostatinergic functions. J. Endocrinol. 1999, 162: 95–99.

    Article  CAS  PubMed  Google Scholar 

  30. Carro E., Seoane L.M., Senaris R., Casanueva F.F., Dieguez C. Leptin increases in vivo GH responses to GHRH and GH-releasing peptide-6 in food-deprived rats. Eur. J. Endocrinol. 2000; 142: 66–70.

    Article  CAS  PubMed  Google Scholar 

  31. Mizuno I., Okimura Y., Takahashi Y., Kaji H., Abe H., Chihara K. Leptin stimulates basal and GHRH-induced GH release from cultured rat anterior pituitary cell in vitro. Kobe J. Med. Sci. 1999, 45: 221–227.

    CAS  PubMed  Google Scholar 

  32. Micić D., Macut Dj., Popović V., et al. Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome. Gynecol. Endocrinol. 1997, 11: 315–320.

    Article  PubMed  Google Scholar 

  33. Wu X., Sallinen K., Zhou S., Su Y., Pollanen P., Erkkola R. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome. Fertil. Steril. 2000, 73: 730–734.

    Article  CAS  PubMed  Google Scholar 

  34. Mauras N. Growth hormone and sex steroids. Interactions in puberty. Endocrinol. Metab. Clin. North. Am. 2001, 30: 529–544.

    Article  CAS  PubMed  Google Scholar 

  35. Ruiz E., Osorio A., Torres J.M., Ortega E. Evidence of different actions of testosterone, estradiol, FSH, and LH on the growth axis. Endocr. Res. 2001, 27: 25–33.

    Article  CAS  PubMed  Google Scholar 

  36. Fisker S., Norrelund H., Juul A., Skakkebaek N.E., Christiansen J.S., Jorgensen J.O. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males. Growth Horm. IGF Res. 2001, 11: 104–109.

    Article  CAS  PubMed  Google Scholar 

  37. Ciampelli M., Muzj G., Lenoni F., et al. Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2001, 86: 5324–5329.

    Article  CAS  PubMed  Google Scholar 

  38. McMahon C.D., Chapin L.T., Radcliff R.P., Lookingland K.J., Tucker H.A. GH- releasing peptide-6 overcomes refractoriness of somatotropes to GHRH after feeding. J. Endocrinol. 2001, 170: 235–241.

    Article  CAS  PubMed  Google Scholar 

  39. Muller A.F., Lamberts S.W., Janssen J.A., et al. Ghrelin drives GH secretion during fasting in man. Eur. J. Endocrinol. 2002, 146: 203–207.

    Article  CAS  PubMed  Google Scholar 

  40. Kasa-Vubu J.Z., Barkan A., Olton P., Meckmongkol T., Carlson N.E., Foster C.M. Incomplet modified fast in obese early pubertal girls leads to an increase in 24-hour growth hormone concentration and a lessening of the circadian pattern in leptin. J. Clin. Endocrinol. Metab. 2002, 87: 1885–1893.

    Article  CAS  PubMed  Google Scholar 

  41. Fernandez-Real J.M., Granada M.L., Ruzafa A., Casamitjana R. Ricart W. Insulin sensitivity and secretion influence the relationship between growth hormone-binding-protein and leptin. Clin. Endocrinol. 2000, 52: 159–164.

    Article  CAS  Google Scholar 

  42. Kristensen K., Pedersen S.B., Fisker S., et al. Serum leptin levels and leptin expression in growth hormone (GH)-de-ficient and healthy adults: influence of GH treatment, gender, and fasting. Metabolism 1998, 47: 1514–1519.

    Article  CAS  PubMed  Google Scholar 

  43. Bergendahl M., Evans W.S., Pastor C., Patel A., Iranmanesh A., Veldhuis J.D. Short-term fasting suppresses leptin and (conversely) activates disorderly growth hormone secretion in midluteal phase women — a clinical research center study. J. Clin. Endocrinol. Metab. 1999, 84: 883–943.

    CAS  PubMed  Google Scholar 

  44. Bergendahl M., Iranmanesch A., Evans W.S., Veldhuis J.D. Short-term fasting selectively supresses leptin pulse mass and 24-hour rhythmic leptin release in healthy midluteal phase women without disturbing leptin pulse frequency or its entropy control (pattern orderliness). J. Clin. Endocrinol. Metab. 2000, 85: 207–213.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dragan Micić*.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Micić*, D., Šumarac-Dumanović, M., Macut, D. et al. Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting. J Endocrinol Invest 26, 333–340 (2003). https://doi.org/10.1007/BF03345181

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345181

Key-words

Navigation